

Chhindwara: In a shocking development following the death of a 5-month-old infant in Bichhua, the district Ayush department has banned the sale, storage and distribution of seven Ayurvedic medicines after they failed quality testing. The lab report declared these medicines NSQ (Not of Standard Quality) and potentially unsafe for public use.
Medicines Linked to Infant’s Death Found Substandard
The action comes after the suspicious death of a baby girl who was given Ayurvedic medicines for cough and cold. During investigation, samples of several medicines used by the family were collected and sent to the Ayush testing lab in Gwalior.
The report revealed that seven medicines failed to meet safety and quality standards.
Companies Involved
Medicines from the following companies have been restricted:
- Unit-II Shree Dhanwantri Herbals, Solan (HP)
- Dabur India Ltd., Sahibabad (UP)
- Shivayu Ayurved Ltd., Aurangabad (Maharashtra)
List of Banned Ayurvedic Medicines
The Ayush department has stopped the sale of these products with immediate effect:
- Giloy Satva
- Kasamrit Syrup
- Kamdudha Ras
- Praval Pishti
- Mukta Shakti Bhasma
- Laxmi Vilas Ras
- Kaphkuthar Ras
Most of these belong to batches expiring between 2025 and 2034.
Two Days Deadline for Disposal Reports
All Ayurvedic health centres and hospitals have been instructed to:
- Remove these medicines from their stocks immediately
- Ensure they are not consumed under any circumstances
- Submit a compliance report to the core team within two days
Strict Warning to Officials
The department has warned that any centre found storing these medicines will face action under the Drugs and Cosmetics Act, 1940 and Rules, 1945. Officers will be held personally responsible.
How the Case Unfolded
On October 30, Sandip Minot from Bichhua purchased Kasamrit syrup and 16 herbal sachets for his infant daughter suffering from cold. Soon after consuming the medicines, the child’s condition deteriorated rapidly and she died.
The grieving family filed a complaint with the Ayush department, following which samples were seized.
While Kasamrit syrup passed the quality test, the herbal sachets failed, triggering a wide-scale investigation and the subsequent ban.
District’s Second Major Action After Toxic Cough Syrup Case
This is the second major crackdown in the district after earlier incidents involving toxic cough syrups that led to multiple child deaths. The department has termed this action crucial for preventing health risks from unsafe Ayurvedic products.
Related
Discover more from SD NEWS agency
Subscribe to get the latest posts sent to your email.
Discover more from Prime Media
Subscribe to get the latest posts sent to your email.
